Zai Lab Cash Flow Statement
NASDAQ: ZLABHealth CareBiotechnology: Pharmaceutical PreparationsUSD
24.99+0.18 (+0.73%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Zai Lab free cash flow
In fiscal 2025, Zai Lab generated -$150.8 million of operating cash flow and spent $8.1 million on capital expenditures. That left free cash flow of -$158.9 million, a free-cash-flow margin of -34.5% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Zai Lab cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -175.54M | -257.10M | -334.62M | -443.29M | -704.47M | -268.90M | -195.07M | -139.07M | -50.38M | -37.51M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 15.01M | 11.86M | 9.03M | 8.23M | 6.49M | 4.64M | 3.77M | 1.65M | 548.00K | 198.22K |
| Stock-Based Compensation | 65.60M | 70.65M | 79.63M | 61.30M | 40.71M | 24.83M | 20.29M | 12.23M | 9.93M | 4.93M |
| Change in Working Capital | -40.23M | -37.43M | 25.28M | -85.46M | 18.09M | 41.53M | -24.47M | 23.56M | 9.33M | -287.39K |
| Operating Cash Flow | -150.79M | -214.87M | -198.18M | -367.64M | -549.23M | -216.06M | -191.01M | -97.54M | -32.37M | -32.16M |
| Capital Expenditures | -8.10M | -5.66M | -7.21M | -24.59M | -18.30M | -10.13M | -6.04M | -10.02M | -9.10M | -2.22M |
| Investing Cash Flow | 307.87M | -375.19M | -10.78M | 420.02M | 249.96M | -554.83M | -14.89M | -212.55M | -10.43M | -2.73M |
| Financing Cash Flow | 72.35M | 349.89M | -6.43M | -1.73M | 820.20M | 1.13B | 219.30M | 144.15M | 187.86M | 106.20M |
| Net Change in Cash | 229.91M | -240.48M | -218.01M | 44.37M | 522.04M | 366.42M | 13.49M | -166.71M | 145.71M | 70.79M |
| Free Cash Flow | -158.89M | -220.53M | -205.39M | -392.23M | -567.53M | -226.19M | -197.05M | -107.55M | -41.47M | -34.38M |
This table shows 10 annual periods of Zai Lab's cash flow statement, from FY 2025 back to FY 2016, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ZLAB's reporting calendar. What is a cash flow statement?